Statement of Changes in Beneficial Ownership (4)
May 18 2020 - 4:21PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Van Strydonck, Gerald E. |
2. Issuer Name and Ticker or Trading Symbol
VACCINEX, INC.
[
VCNX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
|
|
(Last)
(First)
(Middle)
C/O VACCINEX, INC., 1895 MOUNT HOPE AVENUE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
5/14/2020 |
|
(Street)
ROCHESTER, NY 14620
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code
(Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) | 8. Price of Derivative Security
(Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Stock Option (Right to Buy) | $14.90 | | | | | | | (1) | 3/6/2023 | Common Stock | 7500 | | 7500 | D |
|
| Stock Option (Right to Buy) | $13.60 | | | | | | | (1) | 9/15/2027 | Common Stock | 6396 | | 6396 | D |
|
| Stock Option (Right to Buy) | $5.26 | | | | | | | (1) | 3/30/2029 | Common Stock | 2501 | | 2501 | D |
|
| Stock Option (Right to Buy) | $7.78 | | | | | | | 5/15/2020 | (2) | Common Stock | 7718 | | 7718 | D |
|
| Stock Option (Right to Buy) | $5.52 | | | | | | | 6/30/2019 | 6/29/2029 | Common Stock | 2385 | | 2385 | D |
|
| Stock Option (Right to Buy) | $7.17 | | | | | | | 9/30/2019 | 9/27/2029 | Common Stock | 1856 | | 1856 | D |
|
| Stock Option (Right to Buy) | $4.85 | | | | | | | 12/31/2019 | 12/28/2029 | Common Stock | 2737 | | 2737 | D |
|
| Stock Option (Right to Buy) | $3.95 | 5/14/2020 | | A | | 15679 | | 5/14/2021 | (3) | Common Stock | 15679 | $0 | 15679 | D |
|
| Explanation of Responses: |
| (1) | Exercisable in full as of the date of this report. |
| (2) | This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first. |
| (3) | This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Van Strydonck, Gerald E.
C/O VACCINEX, INC.
1895 MOUNT HOPE AVENUE
ROCHESTER, NY 14620 | X |
|
|
|
Signatures
|
| /s/ Scott E. Royer, Attorney-in-Fact for Gerald E. Van Strydonck | | 5/18/2020 |
| **Signature of Reporting Person | Date |
Vaccinex (NASDAQ:VCNX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vaccinex (NASDAQ:VCNX)
Historical Stock Chart
From Apr 2023 to Apr 2024
